Hospital Amaral Carvalho

R. Doná Silvéria, 150 - Chácara Braz Miraglia, Jaú - SP, 17210-080, Brazil

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Patricia Beato

Guilherme Costa

Weslley Aleixo

Edson Barreira

Debora Cristina de Campos Chicacci

Adriana Coutinho

Jonathan dos Santos

Alvaro Lança

Ederson Mattos

Brigida Ranzani

Natalia Rodrigues

Elaine Paris de Oliveira Rosa

Luana Dias Viera

Eloisa Negreiros D. Stivam

Márcia Higashi

Open studies

Chondrosarcoma

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen - CHONQUER - Servier Bio-Innovation LLCSee more

Colorectal cancer

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer - MOUNTAINEER-03 - Seagen Inc.See more

Head and neck cancer

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC - NANORAY-312 - NanobiotixSee more

Leukemia

Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia - VenCM - Hospital Amaral Carvalho. Jau, SP, BrazilSee more

Lung cancer

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) - DeLLphi-306 - AmgenSee more

Multiple myeloma

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) - Successor-1 - Bristol-Myers SquibbSee more

Myeloproliferative syndromes

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment - MYF3001 - Geron CorporationSee more

Non-Hodgkin Lymphoma

Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma - GOLSEEK-1 - CelgeneSee more